title: Pharmacological chaperone therapies: Can aldehyde dehydrogenase activator make us healthier?
authors: Laboratory of Liver Cell Biology, Department of Biomedical Sciences, Faculty of Medicine and Pharmacy, Free University Brussels (VUB), Brussels, Belgium. Electronic address: ldolle@vub.ac.be.
authors: Laurent
authors: L
authors: Dollé
authors: Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: bgao@mail.nih.gov.
authors: Bin
authors: B
authors: Gao
mesh_terms: D000444:Aldehyde Dehydrogenase / Q000378:metabolism*; D000818:Animals; D001549:Benzamides / Q000494:pharmacology*; D052117:Benzodioxoles / Q000494:pharmacology*; D005235:Fatty Liver, Alcoholic / Q000188:drug therapy* / Q000201:enzymology*; D008297:Male
chemical_list: D001549:Benzamides; D052117:Benzodioxoles; D000444:Aldehyde Dehydrogenase
keywords: ALDH2; Acetaldehyde; Alda-1; Pharmacological chaperone